Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for waldenstrom macroglobulinemia (phenotype)
Most Correlated Studies
- CD57-negative and positive cytotoxic T-cells from Waldenstrom's Macroglobulinaemia patients
- Bone marrow of chromosome 6q deletion subjects with Waldenstrom's macroglobulinemia
- B lymphocytes from Waldenstrom’s macroglobulinemia and IgM monoclonal gammopathy (MGUS) patients
- Waldenstrom macroglobulinemia BCWM.1 cells expressing mutant CXCR4 (C1013G)
- Plasma cells and B cells from Waldenström’s macroglobulinemia, multiple myeloma, and CLL
Most Relevant Literature
- Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for…
- Waldenström Macroglobulinemia: Targeted Agents Taking Center Stage.
- Optimizing BTK Inhibition in Waldenström Macroglobulinemia.
- Diagnosis and Risk Stratification in Waldenström Macroglobulinemia.
- Future Directions in the Frontline Management of Waldenström Macroglobulinemia.
Most Relevant Clinical Trials
- Sildenafil Citrate in Waldenstrom's Macroglobulinemia
- Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia
- Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia
- Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
- Simvastatin in Waldenstrom's Macroglobulinemia
